Targeted Protein Degradation (TPD) is ushering in a transformative era in medicine by offering innovative therapeutic strategies that focus on eliminating disease-causing proteins. Unlike traditional therapies that aim to inhibit protein activity, TPD proposes the removal of harmful proteins, which
Private general practitioner (GP) clinics in Malaysia are grappling with intense financial pressures exacerbated by rising costs and global trade instability. Significant among these challenges is the looming potential expansion of US tariffs to pharmaceuticals. This situation poses severe
The announcement from the U.S. Food and Drug Administration (FDA) to gradually phase out animal testing marks a revolutionary shift in drug development. This groundbreaking change aims to replace traditional testing methods with artificial intelligence (AI) and other advanced technologies,
The evolution of the U.S. private healthcare system is a tale of continual adaptation and innovation, shaped by market dynamics, regulatory changes, and technological advances. This comprehensive overview charts the history from the early foundations to emerging future trends in the industry. In
Patients with Inflammatory Bowel Disease (IBD) often grapple with a myriad of challenges that impede their access to timely and effective medical care. Recent studies presented at the Crohn's & Colitis Congress in 2025 have brought to light the significant barriers that insurance issues impose,
Schrödinger, Inc., a company renowned for its computational software in drug discovery, has navigated the biotech landscape for 35 years while traditionally refraining from associating its platform with artificial intelligence (AI). This distinct approach has set Schrödinger apart from pure
